MedTrace Logo

Golgi Protein for HCC Diagnosis

NCT03039322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2017-02-01

No results posted yet for this study

Summary

This case-control study was conducted on 90 patients who were equally divided into two groups. Group 1 included 45 patients with HCV-related chronic liver disease without clinical or radiological evidence of HCC (control group), and Group 2 included 45 patients diagnosed to have HCC by Triphasic abdominal CT (patient group). Serum AFP and GP73 were measured using ELISA technique

Conditions

  • Screening for Hepatocellular Carcinoma

Interventions

DIAGNOSTIC_TEST

Serum Golgi Protein 73

Serum test

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-22
Primary Completion
2015-12-30
Completion
2015-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03039322 on ClinicalTrials.gov